Rubin Paul D's Form 4 filing
BioAge Labs, Inc. (BIOA) · filed Jan 6, 2026
- Accession no.
- 0001210905-26-000002
- Filed
- Jan 6, 2026
- Trade date
- Jan 2, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $95.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rubin Paul DCIK 0001210905 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Common Stock | MOption exerciseAcquired | +5,433 | $4.11 | +$22,329.63 | 5,433 | Direct | |
| Jan 2, 2026 | Common Stock | MOption exerciseAcquired | +2,000 | $6.57 | +$13,140 | 7,433 | Direct | |
| Jan 2, 2026 | Common Stock | SSaleDisposed | −7,433 | $12.85 | −$95,514.05 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | Common Stock | MOption exerciseDisposed | −5,433 | $0.00 | $0 | 16,303 | Direct | |
| Jan 2, 2026 | Common Stock | MOption exerciseDisposed | −2,000 | $0.00 | $0 | 7,383 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.